Literature DB >> 30220711

Excessive tensile strain induced the change in chondrocyte phenotype.

Dongyan Zhong1, X I Chen1, Wen Zhang1, Zong-Ping Luo1.   

Abstract

PURPOSE: Chondrocyte extracellular matrix type II collagen and proteoglycans ensure an important compression-bearing structure in synovial joint. However, much more type I collagen is generated in osteoarthritis, which implies the presence of abnormal tensile strain in cartilage. We hypothesize that tensile stress influences chondrocyte phenotype at the cellular level, leading to potential osteoarthritis.
METHODS: Chondrocytes were stimulated with cyclic excessive tensile (10%) or mild tensile or compressive strain (5%) at 0.5 Hz, 3 h per day for 3 days. Chondrocyte morphology and matrix proteoglycans level was separately determined by Rhodamine phalloidin and toluidine blue staining. The expression of cartilage marker molecules was measured using quantitative reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assays.
RESULTS: Chondrocytes demonstrated significant fibroblastic morphology, reduced proliferation and increased apoptosis following exposure to 10% tensile strain. The 10% tensile strain group induced the lowest matrix proteoglycans level. It observably reduced the expression of COL2A1, Acan and SOX9, and increased COL1A1 expression level. The 5% tensile (5% compression) group, maintained the chondrocyte phenotype.
CONCLUSIONS: The findings identified the effects of different magnitudes of tensile stress on chondrocyte phenotype compared to compressive strain. Further studies on cartilage biomechanical micro-environment might benefit from this study.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30220711

Source DB:  PubMed          Journal:  Acta Bioeng Biomech        ISSN: 1509-409X            Impact factor:   1.073


  1 in total

1.  Local Tensile Stress in the Development of Posttraumatic Osteoarthritis.

Authors:  Dongyan Zhong; Meng Zhang; Jia Yu; Zong-Ping Luo
Journal:  Biomed Res Int       Date:  2018-11-04       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.